Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncogene

Showing results (1301-1310 of 22,015) with videos related to

Pageof 2,202
Sort By:
Oncogene|June 10, 2018
Forkhead box C1 promotes colorectal cancer metastasis through transactivating ITGA7 and FGFR4 expressionJian Liu, Zhe Zhang, Xiaowei Li, et al.
Oncogene|August 9, 2018
Hsp90β promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinomaJing Meng, Shuang Chen, Yue-Yang Lei, et al.
Oncogene|August 11, 2018
Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansionLinping Chen-Wichmann, Marina Shvartsman, Caro Preiss, et al.
Oncogene|August 11, 2018
Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcomaYang W Shao, Geoffrey A Wood, Jinchang Lu, et al.
Oncogene|July 5, 2018
Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiREunjee Lee, Ana Collazo-Lorduy, Mireia Castillo-Martin, et al.
Oncogene|May 22, 2018
NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppressionSheng Tan, Hua Li, Weijie Zhang, et al.
Oncogene|May 22, 2018
LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapyLeonie Rossow, Simona Veitl, Sandra Vorlová, et al.
Oncogene|May 23, 2018
Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapyBo Zhu, Liming Tang, Shuyang Chen, et al.
Oncogene|October 1, 1988
hst-1 transforming protein: expression in silkworm cells and characterization as a novel heparin-binding growth factorK Miyagawa, H Sakamoto, T Yoshida, et al.
Oncogene|November 1, 1988
DNA binding properties of murine p53K Steinmeyer, W Deppert
Pageof 2,202

Showing results (1301-1310 of 22,015) with videos related to

Sort By:
Pageof 2,202
Oncogene|June 10, 2018
Forkhead box C1 promotes colorectal cancer metastasis through transactivating ITGA7 and FGFR4 expressionJian Liu, Zhe Zhang, Xiaowei Li, et al.
Oncogene|August 9, 2018
Hsp90β promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinomaJing Meng, Shuang Chen, Yue-Yang Lei, et al.
Oncogene|August 11, 2018
Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansionLinping Chen-Wichmann, Marina Shvartsman, Caro Preiss, et al.
Oncogene|August 11, 2018
Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcomaYang W Shao, Geoffrey A Wood, Jinchang Lu, et al.
Oncogene|July 5, 2018
Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiREunjee Lee, Ana Collazo-Lorduy, Mireia Castillo-Martin, et al.
Oncogene|May 22, 2018
NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppressionSheng Tan, Hua Li, Weijie Zhang, et al.
Oncogene|May 22, 2018
LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapyLeonie Rossow, Simona Veitl, Sandra Vorlová, et al.
Oncogene|May 23, 2018
Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapyBo Zhu, Liming Tang, Shuyang Chen, et al.
Oncogene|October 1, 1988
hst-1 transforming protein: expression in silkworm cells and characterization as a novel heparin-binding growth factorK Miyagawa, H Sakamoto, T Yoshida, et al.
Oncogene|November 1, 1988
DNA binding properties of murine p53K Steinmeyer, W Deppert
Pageof 2,202